ARROWHEAD PHARMACEUTICALS, INC. ARWR
Nasdaq · XNAS · stock · Pharmaceutical Preparations · website · IPO 1993-12-14
ARROWHEAD PHARMACEUTICALS, INC. insider transactions (Form 4)
| Insider | Role | Date | Action | Shares | Price |
|---|---|---|---|---|---|
| Cohen Matthew Gregory | director | 2026-06-15 | Grant | 11,882 | — |
| Lu Hongbo | director | 2026-05-12 | Sell | 2,970 | $76.88 |
| Hamilton James C | Chief Medical Officer | 2026-04-23 | Sell | 10,000 | $75.00 |
| Apel Daniel Joseph | Chief Financial Officer | 2026-04-22 | Sell | 3,208 | $70.11 |
| Apel Daniel Joseph | Chief Financial Officer | 2026-04-22 | Sell | 8,730 | $71.92 |
| Apel Daniel Joseph | Chief Financial Officer | 2026-04-22 | Sell | 1,157 | $70.45 |
| Hamilton James C | Chief Medical Officer | 2026-03-05 | Sell | 10,000 | $64.19 |
| Hamilton James C | Chief Medical Officer | 2026-01-06 | Grant | 75,000 | — |
Source: SEC EDGAR filings · CIK 0000879407 · as of 2025-09-30. Facts from filings plus Stocktoria's own computed scores — not investment advice.